NPR3 and coronary artery disorder: Although the underlying pathophysiological mechanisms of EAT in CAD progression are not completely understood, recent evidence suggests that low levels of the EAT NPR-C expression may lead to dysregulation of the epicardial fat surrounding the myocardium, which in turn may contribute, at least in part, to the progression of CAD (Moreno-Santos et al., 2019).